Location History:
- Rehovoth, IL (1984 - 1987)
- Rehovot, IL (1983 - 2008)
Company Filing History:
14 out of 1,168 
2 out of 10 
2 out of 45 Years Active: 1983-2008
Title: The Innovative Contributions of Meir Wilchek
Introduction
Meir Wilchek, a prominent inventor based in Rehovot, IL, has made significant strides in the field of bioengineering and pharmaceuticals. With a remarkable portfolio of 17 patents, Wilchek's contributions focus on the therapeutic applications of allicin, a compound known for its medicinal properties. His innovative methodologies have opened new avenues in cancer treatment and management of infectious diseases.
Latest Patents
Among his latest patents, two stand out for their groundbreaking implications. The first, titled "Site-specific in situ generation of allicin using a targeted alliinase delivery system for the treatment of cancers, tumors, infectious diseases and other allicin-sensitive diseases," involves the conjugation of the enzyme alliinase with a protein carrier. This innovative system enables targeted delivery to specific cells, effectively generating allicin at desired locations to combat cancer cells and pathogens. The second patent, "Allylmercaptocaptopril compounds and uses thereof," explores compounds created from the reaction of allicin with ACE-inhibiting substances, proving useful in treating hypertension, elevated triglycerides, and insulin levels.
Career Highlights
Meir Wilchek's illustrious career includes pivotal roles at renowned institutions such as Yeda Research and Development Company and Biosepra Inc. His work has continually pushed the boundaries of conventional medicine, focusing on practical applications for his inventions in real-world settings.
Collaborations
Throughout his professional journey, Wilchek has collaborated with noteworthy colleagues, including Edward A. Bayer and Alexander Schwarz. These partnerships have fostered an environment of innovation, leading to the successful development and patenting of several critical compounds that enhance therapeutic options for various medical conditions.
Conclusion
In summary, Meir Wilchek's extensive patent portfolio and his commitment to advancing medical science underscore his status as an influential inventor. His pioneering work in the targeted application of allicin represents a significant advancement in the treatment of cancer and infectious diseases, reflecting the profound impact of his innovations on modern medicine.